Clinical Trials Browser

Phase 2 × sapanisertib × Gynecologic × Clear all

NCT06463028 2025-12-24

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Phase 2 Recruiting

Genital Diseases, Hereditary Sensory and Autonomic Neuropathies, Endometrial Neoplasms, Carcinoma, Endometrioid

NCT03648489 2024-09-20

DICE

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02725268 2021-11-24

A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer

Phase 2 Completed

241 enrolled 22 charts

Endometrial Neoplasms